The vaccine effectiveness was 50 % ( 95 % CI 32-63 ) in the 30,527 infants with three plus one and two plus one schedules combined and the absolute incidence rate reduction was 207 episodes per 100,000 person-years ( 95 % CI 127-286 ) .